Laramie, United States
Unlocked Labs, founded in 2018 and headquartered in the United States, is positioned at the forefront of the Biotechnology and Health Care industries. The company's mission centers on optimizing probiotics to target and eliminate toxins from the body, significantly reducing the risk of painful health events.
Boasting their slogan, "Optimized probiotics for targeted outcomes," Unlocked Labs leverages a platform approach to activate dormant microbial enzymes. This innovative method sequesters and biodegrades specific toxins, empowering patients with easy-to-access health management tools.
The company recently secured a Pre Seed Round investment on 03 April 2024, backed by Seaside Ventures. This early-stage investment reflects growing confidence in Unlocked Labs’ unique approach and potential to drive advancements in personalized health solutions. Potential investors will find a promising opportunity in the company's current trajectory and specialized offering.
